SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-047373
Filing Date
2022-04-19
Accepted
2022-04-19 16:43:38
Documents
6
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm223584d1_pre14a.htm PRE 14A 1098833
2 GRAPHIC tm223584d1_pre14acvr01.jpg GRAPHIC 191109
3 GRAPHIC tm223584d1_pre14acvr02.jpg GRAPHIC 132489
4 GRAPHIC tm223584d1_pre14aimg0001.jpg GRAPHIC 10861
5 GRAPHIC tm223584d1_pre14asp4img02.jpg GRAPHIC 3248
6 GRAPHIC tm223584d1_pre14asp4img03.jpg GRAPHIC 3791
  Complete submission text file 0001104659-22-047373.txt   1570918
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36294 | Film No.: 22835365
SIC: 2834 Pharmaceutical Preparations